A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer
Clinical trial NCT06974929 · RECRUITING
Trial details
- NCT number
- NCT06974929
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-22
- Primary completion
- 2026-12-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.